Population screening for beta-thalassemia minor. Report of cooperative trials based on two approaches.
In a cooperative intrastate program based upon experience with sickle-cell anemia screening, the authors explored the feasibility of applying hemoglobin electrophoresis for detection of beta-thalassemia gene carriers. Initially, blood samples collected in capillary tubes were analyzed by cellulose acetate electrophoresis with densitometric quantitation of hemoglobin A2 (Hb A2), followed by selective spectrophotometric quantitation. This approach proved insufficiently specific or reproducible. Follow-up hematologic and family studies of presumptive beta-thalassemia gene carriers indicated that coordinate measurement of erythrocytic indices and Hb A2 values would have discriminated a subpopulation with a high incidence of beta-thalassemia trait more specifically. This approach was tested prospectively by the use of 731 venous blood samples collected in a county with a large population of Mediterranean ancestry. Of 31 individuals (4.2%) with presumptive thalassemia trait, 13 returned for a repeat testing, and the initial results for 11 were confirmed. These findings lend support to an empirical screening sequence suggested by Pearson (erythrocytic indices followed by Hb A2 quantitation), but they also indicate that a significant subpopulation of beta-thalassemia gene carriers with limited phenotypic expression may elude detection in any single-pass approach.
D001797:Blood Protein Electrophoresis; D001800:Blood Specimen Collection; D003720:Densitometry; D004588:Electrophoresis, Cellulose Acetate; D004913:Erythrocytes, Abnormal / Q000166:cytology; D005500:Follow-Up Studies; D006580:Genetic Carrier Screening; D006441:Hemoglobin A / Q000032:analysis*; D006443:Hemoglobin A2 / Q000032:analysis*; D006801:Humans; D008403:Mass Screening; D009518:New York; D013053:Spectrophotometry; D013789:Thalassemia / Q000453:epidemiology* / Q000235:genetics
D006441:Hemoglobin A; D006443:Hemoglobin A2